p53 Modulates Radiosensitivity in Head and Neck Cancers—From Classic to Future Horizons

p53, initially considered a tumor suppressor, has been the subject of research related to cancer treatment resistance in the last 30 years. The unfavorable response to multimodal therapy and the higher recurrence rate, despite an aggressive approach, make HNSCC a research topic of interest for impro...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	Diagnostics (Basel) Ročník 12; číslo 12; s. 3052
Hlavní autori:	Mireștean, Camil Ciprian, Iancu, Roxana Irina, Iancu, Dragoș Petru Teodor
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	Switzerland MDPI AG 01.12.2022 MDPI
Predmet:	Apoptosis Biomarkers Cancer therapies Care and treatment Cell cycle Cell division Chemotherapy DNA damage Head & neck cancer Head and neck cancer head and neck cancers Health aspects HNSCC Kinases Metabolism Methods Mutation Ovarian cancer p53 Phase transitions Radiation radioresistance radiosensitivity Radiotherapy Review Tumor proteins Tumors Romania radiotherapy head and neck cancers HNSCC radioresistance radiosensitivity p53
ISSN:	2075-4418, 2075-4418
On-line prístup:	Získať plný text
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!